© 2025 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

MSU pushes potential Parkinson's drug to clinical trial

Courtesy - Michigan State University

Neurodegenerative disorders such as Parkinson’s and Alzheimer’s cost the U-S billions of dollars each year. Last year, a study supported by the National Institutes of Health found that in 2010, the cost of treating Alzheimer’s alone neared $215-billion.These devastating illnesses also take a huge emotional toll on both the victims and their loved ones.

Current State’s Kevin Lavery reports that a team at Michigan State University is studying a protein molecule that it feels may become a new drug in the fight against degenerative diseases.

They say they’re ready to make the leap to clinical trials. 

Kevin Lavery served as a general assignment reporter and occasional local host for Morning Edition and All Things Considered before retiring in 2023.
Related Content
Local journalism matters—and it’s at risk.


WKAR brings you trusted news, without barriers—no paywalls, no corporate spin. But now, federal funding that helps make it all possible is on the chopping block. Your support is more important than ever. Stand up for independent journalism in mid-Michigan—make your gift today.